Marie-Éve Goyer

“COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada

S. Glegg, B. Le Foll, T. Brothers, 2022, International Journal of Drug Policy.

Seeking shelter: homelessness and COVID-19

Andrew S. Boozary, S. Baral, A. Robertson, 2021, FACETS.

M2HepPrEP: study protocol for a multi-site multi-setting randomized controlled trial of integrated HIV prevention and HCV care for PWID

V. Martel-Laferrière, C. Loignon, L. Metsch, 2019, Trials.

Management of opioid use disorders: a national clinical practice guideline

Evan Wood, Benedikt Fischer, T. Cameron Wild, 2018, Canadian Medical Association Journal.

The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19

S. Glegg, B. Le Foll, N. Fairbairn, 2022, Harm Reduction Journal.

Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans

S. Glegg, B. Le Foll, N. Fairbairn, 2021, CMAJ open.

Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline

B. Le Foll, E. Oviedo-Joekes, N. Fairbairn, 2019, Canadian Medical Association Journal.

Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders

Judith Sabetti, Léonie Archambault, Michel Perreault, 2022, Drugs: Education, Prevention and Policy.